These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16390350)

  • 1. Limited predictability of amikacin clearance in extreme premature neonates at birth.
    Allegaert K; Anderson BJ; Cossey V; Holford NH
    Br J Clin Pharmacol; 2006 Jan; 61(1):39-48. PubMed ID: 16390350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine is not an independent risk factor for reduced amikacin clearance in extremely low-birth-weight infants.
    Allegaert K; Debeer A; Cossey V; Rayyan M; Devlieger H
    Pediatr Crit Care Med; 2006 Mar; 7(2):143-6. PubMed ID: 16446602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of ibuprofen administration on renal drug clearance in the first weeks of life.
    Allegaert K; Rayyan M; Anderson BJ
    Methods Find Exp Clin Pharmacol; 2006 Oct; 28(8):519-22. PubMed ID: 17136231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life.
    Allegaert K; Cossey V; Langhendries JP; Naulaers G; Vanhole C; Devlieger H; Van Overmeire B
    Biol Neonate; 2004; 86(3):207-11. PubMed ID: 15249757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of ibuprofen or indomethacin on renal drug clearance in neonates.
    Allegaert K
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():88-91. PubMed ID: 19701859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and size are the major covariates for prediction of levobupivacaine clearance in children.
    Chalkiadis GA; Anderson BJ
    Paediatr Anaesth; 2006 Mar; 16(3):275-82. PubMed ID: 16490091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation.
    Bleyzac N; Varnier V; Labaune JM; Corvaisier S; Maire P; Jelliffe RW; Putet G; Aulagner G
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):499-504. PubMed ID: 11699615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal drug clearance in preterm neonates: relation to prenatal growth.
    Allegaert K; Anderson BJ; van den Anker JN; Vanhaesebrouck S; de Zegher F
    Ther Drug Monit; 2007 Jun; 29(3):284-91. PubMed ID: 17529884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.
    De Cock RF; Allegaert K; Schreuder MF; Sherwin CM; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2012 Feb; 51(2):105-17. PubMed ID: 22229883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring of amikacin in preterm and term infants.
    Siddiqi A; Khan DA; Khan FA; Razzaq A
    Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of amikacin in neonates.
    Padovani EM; Pistolesi C; Fanos V; Messori A; Martini N
    Dev Pharmacol Ther; 1993; 20(3-4):167-73. PubMed ID: 7828449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of intrauterine maturation on the pharmacokinetics of amikacin in the neonatal period.
    Assael BM; Parini R; Rusconi F; Cavanna G
    Pediatr Res; 1982 Oct; 16(10):810-5. PubMed ID: 7145504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amikacin in neonates: dosing recommendations should be based on both pharmacokinetics and dynamics.
    Allegaert K; Sherwin CM
    Singapore Med J; 2010 Jan; 51(1):88-9. PubMed ID: 20200782
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the concomitant administration of indomethacin or ibuprofen on amikacin pharmacokinetics in premature newborns].
    Cuesta Grueso C; Gimeno Navarro A; Marqués Miñana MR; Peris Ribera JE; Morcillo Sopena F; Poveda Andrés JL
    Farm Hosp; 2006; 30(3):149-53. PubMed ID: 16999561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of gestational age and birth weight on amikacin clearance on day 1 of life.
    Schreuder MF; Wilhelm AJ; Bökenkamp A; Timmermans SM; Delemarre-van de Waal HA; van Wijk JA
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1774-8. PubMed ID: 19713296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sepsis upon gentamicin pharmacokinetics in neonates.
    Lingvall M; Reith D; Broadbent R
    Br J Clin Pharmacol; 2005 Jan; 59(1):54-61. PubMed ID: 15606440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.